Diabetic pharmacotherapy use among those individuals holding at least one valid prescription for an antihyperglycemic agent at the time of initial ccCHiP clinic visit (n=229)
| Antihyperglycemic agent | n (%) holding a valid prescription |
| Metformin | 216 (94.3) |
| Gliclazide (or other sulfonylurea) | 44 (19.2) |
| DPP4 inhibitor | 26 (11.4) |
| GLP-1 receptor agonist | 1 (0.4) |
| SGLT2 inhibitor | 17 (7.4) |
| Insulin | 36 (15.7) |
ccCHiP, Collaborative Centre for Cardiometabolic Health in Psychosis.